首页> 外文期刊>Chemotherapy: International Journal of Experimental and Clinical Chemotherapy >Antibiotic susceptibility testing (agar disk diffusion and agar dilution) of clinical isolates of Enterococcus faecalis and E. faecium: comparison of Mueller-Hinton, Iso-Sensitest, and Wilkins-Chalgren agar media.
【24h】

Antibiotic susceptibility testing (agar disk diffusion and agar dilution) of clinical isolates of Enterococcus faecalis and E. faecium: comparison of Mueller-Hinton, Iso-Sensitest, and Wilkins-Chalgren agar media.

机译:粪肠球菌和粪肠球菌临床分离株的药敏试验(琼脂圆盘扩散和琼脂稀释):Mueller-Hinton,Iso-Sensitest和Wilkins-Chalgren琼脂培养基的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

Forty-two isolates of Enterococcus faecalis and 56 isolates of Enterococcus faecium, including 8 vancomycin-resistant strains, were examined for comparative susceptibility to 27 antimicrobial drugs with the agar dilution method, employing Mueller-Hinton (MHA), Iso-Sensitest (ISTA), and Wilkins-Chalgren (WCA) agar. The Bauer-Kirby agar disk diffusion method was used to comparatively test 24 of the agents in parallel. The enterococci yielded better growth on ISTA and WCA. However, WCA completely antagonized co-trimoxazole and, though less, fosfomycin. Importantly, WCA slightly reduced the activities of teicoplanin (minimal inhibitory concentrations, MICs, raised up to twofold) and vancomycin (MICs raised two- to fourfold) against enterococci and staphylococcal quality control strains. Therefore, WCA was judged unsuitable for susceptibility testing of enterococci. For E. faecalis no discrepancies between agar dilution MICs and inhibition zone diameters were encountered with augmentin, ampicillin, ampicillin-sulbactam, chloramphenicol, mupirocin, oxacillin, teicoplanin, and co-trimoxazole. Overall, MHA yielded fewer very major (category I) and major (category II) discrepancies than ISTA. However, numerous minor (category III), slight (category IV), minimal (category V), and/or negligible (category VI) discrepancies were encountered with ciprofloxacin, doxycycline, erythromycin, fosfomycin, fusidic acid, meropenem, ofloxacin and rifampin. With respect to E. faecium, only cefotaxime, mupirocin, oxacillin, and teicoplanin yielded nondiscrepant results. Several very major (I) and major (II) discrepancies were observed with augmentin, ampicillin, ampicillin-sulbactam, doxycycline, fusidic acid, imipenem, and penicillin G. Minor discrepancies (categories III-VI) were particularly numerous with augmentin, chloramphenicol, ciprofloxacin, doxycycline, and piperacillin. The largest numbers of negligible (VI) discrepancies were noted with fosfomycin, fusidic acid, and ofloxacin. It is recommended to test one cephalosporin (cefuroxime or the like) in parallel for educational purposes and to exclude fosfomycin, fusidic acid, and rifampin from test batteries because of the wide scatter of test results. The large number of minimal (V) discrepancies of ciprofloxacin against E. faecalis, the numerous minor (III) and slight (IV) discrepancies of chloramphenicol against E. faecium, and the not insignificant number of very major (I) and minor (III) discrepancies observed with meropenem against isolates of E. faecalis necessitated proposals for new disk intermediate susceptibility criteria.
机译:采用琼脂稀释法,采用Mueller-Hinton(MHA),Iso-Sensitest(ISTA),采用琼脂稀释法检查了42株粪肠球菌和56株粪肠球菌(包括8种耐万古霉素的菌株)的比较敏感性。 ,以及Wilkins-Chalgren(WCA)琼脂。 Bauer-Kirby琼脂圆盘扩散法用于比较平行测试24种药物。肠球菌在ISTA和WCA上产生了更好的生长。但是,WCA完全拮抗了复方新诺明和磷霉素(尽管较少)。重要的是,WCA稍微降低了替考拉宁(最低抑菌浓度,MIC,提高至两倍)和万古霉素(MIC提高至两倍至四倍)针对肠球菌和葡萄球菌质量控制菌株的活性。因此,WCA被认为不适合肠球菌药敏试验。对于粪肠球菌,扩增素,氨苄青霉素,氨苄青霉素-舒巴坦,氯霉素,莫匹罗星,奥沙西林,替考拉宁和co-trimoxazole在琼脂稀释MIC和抑制区直径之间均未发现差异。总体而言,与ISTA相比,MHA产生的非常重大(I类)和重大(II类)差异更少。但是,环丙沙星,强力霉素,红霉素,磷霉素,夫西地酸,美罗培南,氧氟沙星和利福平存在许多次要的差异(III类),轻微的(IV类),最小的(V类)和/或微不足道的(VI类)差异。对于屎肠球菌,只有头孢噻肟,莫匹罗星,奥沙西林和替考拉宁产生无差别的结果。增强素,氨苄青霉素,氨苄青霉素-舒巴坦,强力霉素,夫西地酸,亚胺培南和青霉素G有几个非常严重的(I)和主要(II)差异。较小的差异(III-VI类)特别多,其中有增强素,氯霉素,环丙沙星,强力霉素和哌拉西林。磷霉素,夫西地酸和氧氟沙星的最大可忽略不计(VI)差异。出于教育目的,建议并行测试一种头孢菌素(头孢呋辛等),并由于测试结果的分散性,从测试电池中排除磷霉素,夫西地酸和利福平。环丙沙星对粪肠球菌的最小差异(V)差异,氯霉素对粪便肠球菌的数量众多的轻度(III)和轻度(IV)差异,以及非常大的(I)和次要(III)的差异不显着)美罗培南与粪肠球菌的分离株之间的差异需要新的磁盘中间药敏标准的建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号